Jury to listen to closing arguments in N.Y. opioid case towards drugmakers

48

Dec 8 (Reuters) – Jurors in a New York state court docket are anticipated to listen to closing arguments Wednesday over whether or not drugmakers AbbVie Inc (ABBV.N) and Teva Pharmaceutical Industries Ltd (TEVA.TA) fueled an opioid epidemic within the state, concluding a trial that has lasted greater than 5 months.

New York’s Attorney General and Nassau and Suffolk Counties are in search of to carry the 2 corporations answerable for the price of coping with opioid dependancy. The corporations have mentioned they complied with federal laws and that altering requirements of care had been behind surging opioid prescriptions.

The case is certainly one of greater than 3,300 filed by state, native and tribal governments throughout the nation accusing drugmakers of minimizing opioid medicine’ addictiveness and distributors and pharmacies of ignoring pink flags that they had been being diverted into unlawful channels.

Register now for FREE limitless entry to reuters.com

On Tuesday, jurors noticed the final proof within the case, together with two parody movies made in 2006 for a gross sales assembly at Cephalon Inc, later purchased by Teva.

One video confirmed the character Dr. Evil from the movie “Austin Powers” as a Cephalon worker complaining about child-resistant packaging on the corporate’s opioid drug Fentora. The different spoofed a courtroom scene in “A Few Good Men” and featured a Cephalon worker telling a lawyer that he “can’t handle the truth” about how gross sales representatives meet quotas.

More than 100,000 folks died from drug overdoses in the course of the 12-month interval ending April 2021, the U.S. Centers for Disease Control and Prevention mentioned in a report in November, a document pushed largely by opioids.

The three largest U.S. drug distributors and Johnson & Johnson (JNJ.N) in July agreed to pay as much as $26 billion to resolve the lawsuits towards them.

A chapter choose in September accepted a settlement by OxyContin maker Purdue Pharma LP, together with about $4.5 billion from its rich Sackler household house owners.

Register now for FREE limitless entry to reuters.com

Reporting By Brendan Pierson in New York, Editing by Alexia Garamfalvi and Aurora Ellis

REUTERS/George Frey

A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange July 18, 2014. REUTERS/Brendan McDermid

The logo of Teva Pharmaceutical Industries is seen in Tel Aviv, Israel February 19, 2019. REUTERS/Amir Cohen

Comments are closed.